iShares Biotechnology ETF (IBB) |
| 189.55 -2.51 (-1.31%) 07-13 16:00 |
| Open: | 190.85 |
| High: | 191.17 |
| Low: | 187.91 |
| Volume: | 1,898,728 |
| Market Cap: | 9,231(M) |
| PE Ratio: | 24.53 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 232.49 |
| Resistance 1: | 199.05 |
| Pivot price: | 189.49 |
| Support 1: | 178.54 |
| Support 2: | 165.86 |
| 52w High: | 199.05 |
| 52w Low: | 128.84 |
The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 13 Jul 2026
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance? - AOL.com
Sun, 12 Jul 2026
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance? - Yahoo Finance
Sat, 11 Jul 2026
Healthcare ETFs Face-Off: Stability vs. Biotech Growth, Which Strategy Wins? - finance.biggo.com
Fri, 10 Jul 2026
5 Best Biotech ETFs for 2026 and How to Invest - The Motley Fool
Fri, 10 Jul 2026
IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy? - The Motley Fool
Fri, 10 Jul 2026
IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy? - The Globe and Mail
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
